Amphastar, Watson Renew Appeal to Lift Generic Lovenox Ban

Amphastar and Watson Pharmaceuticals are again appealing a federal court’s decision to uphold an injunction barring them from selling generic versions of Sanofi’s blockbuster blood-thinner Lovenox.
Generic Line